- No posts yet.
- HIQA publishes batch of inspection reports revealing compliance gaps in older people and disability services across Ireland 7-day briefing • 2026-07-21 - 2026-07-27
- Ireland's health governance enters a two-speed regime: regulatory enforcement intensifies through HIQA while systemic reform remains stalled. 365-day briefing • 2025-07-28 - 2026-07-27
- HIQA publishes 73 inspection reports on older people and disability residential centres with mixed compliance results 7-day briefing • 2026-07-20 - 2026-07-26
- HIQA publishes updated list of 38 designated disability centres across Ireland. 7-day briefing • 2026-07-13 - 2026-07-19
- HIQA annual report reveals expanded regulatory scope including private hospital inspections and home support licensing 7-day briefing • 2026-06-29 - 2026-07-05
- HIQA expands regulation with private hospital inspections, home support licensing, and health data strategy in 2025 annual report. 7-day briefing • 2026-06-22 - 2026-06-28
- HIQA solidifies dual evidence-regulatory role; HSE workforce crisis fades from weekly briefings. 30-day briefing • 2026-05-24 - 2026-06-22
- HIQA publishes alcohol risk models, mental health review, and HTA protocol for severe neurological impairment 7-day briefing • 2026-06-15 - 2026-06-21
- First human trial of AI-designed universal coronavirus vaccine and promising cancer drug results lead medical advances this week 7-day briefing • 2026-05-31 - 2026-06-06
- Ireland's health system faces record waiting lists and low booster uptake as new plans draw criticism 7-day briefing • 2026-05-17 - 2026-05-23
- FDA approves Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older fda.gov | 657d ago
- FDA approves Guardant Health Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older accessdata.fda.gov | 731d ago
- FDA Approves Guardant Health Shield Blood Test for Colorectal Cancer Screening in Average-Risk Adults Aged 45 and Older accessdata.fda.gov | 731d ago
- FDA approves Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older accessdata.fda.gov | 920d ago
- FDA-approved Guardant Shield blood test for colorectal cancer screening: performance characteristics and limitations accessdata.fda.gov | 1122d ago
- FDA Guidance on Post-Approval Studies for PMA Medical Devices (2022 Update) fda.gov | 1389d ago
Showing page 1 of 2
(23 total results)
← Prev
Next →